Medication-Assisted Treatment for Opioid-Use Disorder

Mayo Clin Proc. 2019 Oct;94(10):2072-2086. doi: 10.1016/j.mayocp.2019.03.029. Epub 2019 Sep 19.

Abstract

The United States is in the midst of a national opioid epidemic. Physicians are encouraged both to prevent and treat opioid-use disorders (OUDs). Although there are 3 Food and Drug Administration-approved medications to treat OUD (methadone, buprenorphine, and naltrexone) and there is ample evidence of their efficacy, they are not used as often as they should. We provide a brief review of the 3 primary medications used in the treatment of OUD. Using data from available medical literature, we synthesize existing knowledge and provide a framework for how to determine the optimal approach for outpatient management of OUD with medication-assisted treatments.

Publication types

  • Review

MeSH terms

  • Algorithms
  • Buprenorphine / therapeutic use*
  • Decision Trees
  • Humans
  • Methadone / therapeutic use*
  • Naltrexone / therapeutic use*
  • Opiate Substitution Treatment*
  • Opioid-Related Disorders / drug therapy*

Substances

  • Buprenorphine
  • Naltrexone
  • Methadone